STRIDE
Sponsors
University of New Mexico, VA Office of Research and Development, Massachusetts General Hospital, Joslin Diabetes Center, AstraZeneca
Conditions
Adherence, MedicationBreast CancerDementiaDiabetesEarly AmbulationHepatocellular CarcinomaHormone Receptor Positive Breast CancerHypoglycemia; Drug
Unknown Phase
Mediators and Moderators of Exercise Behavior Change
CompletedNCT01091857
Start: 2004-09-30End: 2009-08-31Updated: 2023-07-11
Optimizing Function and Independence Through STRIDE
CompletedNCT03300336
Start: 2017-10-05End: 2021-10-30Updated: 2023-09-28
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
CompletedNCT03837496
Start: 2019-10-28End: 2021-12-01Updated: 2022-11-18
Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's
CompletedNCT05535478
Start: 2023-01-31End: 2025-07-14Updated: 2025-07-30
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.
RecruitingNCT07607769
Start: 2026-04-16End: 2028-10-31Target: 200Updated: 2026-08-27
Telehealth Intervention for Symptom Management and Adherence to Adjuvant Endocrine Therapy
Not yet recruitingNCT07759947
Start: 2027-02-01End: 2031-06-01Target: 400Updated: 2026-08-12